Literature DB >> 16741901

Predictors of clinical outcome in children undergoing orthotopic liver transplantation for acute and chronic liver disease.

Chris Rhee1, Kiran Narsinh, Robert S Venick, Ricardo A Molina, Visal Nga, Rita Engelhardt, Martín G Martín.   

Abstract

The current United Network for Organ Sharing (UNOS) policy is to allocate liver grafts to pediatric patients with chronic liver disease based on the pediatric end-stage liver disease (PELD) scoring system, while children with fulminant hepatic failure may be urgently listed as Status 1a. The objective of this study was to identify pre-transplant variables that influence patient and graft survival in those children undergoing LTx (liver transplantion) for FHF (fulminant hepatic failure) compared to those patients transplanted for extrahepatic biliary atresia (EHBA), a chronic form of liver disease. The UNOS Liver Transplant Registry was examined for pediatric liver transplants performed for FHF and EHBA from 1987 to 2002. Variables that influenced patient and graft survival were assessed using univariate and multivariate analysis. Kaplan-Meier analysis of FHF and EHBA groups revealed that 5 year patient and graft survival were both significantly worse (P < 0.0001) in those patients who underwent transplantation for FHF. Multivariate analysis of 29 variables subsequently revealed distinct sets of factors that influenced patient and graft survival for both FHF and EHBA. These results confirm that separate prioritizing systems for LTx are needed for children with chronic liver disease and FHF; additionally, our findings illustrate that there are unique sets of variables which predict survival following LTx for these two groups.

Entities:  

Mesh:

Year:  2006        PMID: 16741901     DOI: 10.1002/lt.20806

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  12 in total

Review 1.  Primary malignant liver tumors in children.

Authors:  Sandeep Agarwala
Journal:  Indian J Pediatr       Date:  2012-03-01       Impact factor: 1.967

2.  Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience.

Authors:  Pierre Bourgoin; Aicha Merouani; Véronique Phan; Catherine Litalien; Michel Lallier; Fernando Alvarez; Philippe Jouvet
Journal:  Pediatr Nephrol       Date:  2013-12-06       Impact factor: 3.714

3.  Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.

Authors:  Tomohide Hori; Toshimi Kaido; Fumitaka Oike; Yasuhiro Ogura; Kohei Ogawa; Yukihide Yonekawa; Koichiro Hata; Yoshiya Kawaguchi; Mikiko Ueda; Akira Mori; Hajime Segawa; Kimiko Yurugi; Yasutsugu Takada; Hiroto Egawa; Atsushi Yoshizawa; Takuma Kato; Kanako Saito; Linan Wang; Mie Torii; Feng Chen; Ann-Marie T Baine; Lindsay B Gardner; Shinji Uemoto
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

4.  Pediatric acute liver failure: variations in referral timing are associated with disease subtypes.

Authors:  Ekkehard Sturm; Willem S Lexmond; Henkjan J Verkade
Journal:  Eur J Pediatr       Date:  2014-07-09       Impact factor: 3.183

5.  Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure.

Authors:  Brandy R Lu; Song Zhang; Michael R Narkewicz; Steven H Belle; Robert H Squires; Ronald J Sokol
Journal:  J Pediatr       Date:  2012-12-20       Impact factor: 4.406

6.  Immunophenotype predicts outcome in pediatric acute liver failure.

Authors:  John Bucuvalas; Lisa Filipovich; Nada Yazigi; Michael R Narkewicz; Vicky Ng; Steven H Belle; Song Zhang; Robert H Squires
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-03       Impact factor: 2.839

7.  Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.

Authors:  Chung-Chou H Chang; Cindy L Bryce; Benjamin L Shneider; Jonathan G Yabes; Yi Ren; Gabriel L Zenarosa; Heather Tomko; Drew M Donnell; Robert H Squires; Mark S Roberts
Journal:  JAMA Pediatr       Date:  2018-11-01       Impact factor: 16.193

8.  Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes.

Authors:  Rekha V Thammana; Stuart J Knechtle; Rene Romero; Thomas G Heffron; Caroline T Daniels; Rachel E Patzer
Journal:  Liver Transpl       Date:  2013-12-12       Impact factor: 5.799

9.  Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combination.

Authors:  Tomohide Hori; Hiroto Egawa; Shinji Uemoto
Journal:  Ann Gastroenterol       Date:  2012

10.  Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume.

Authors:  Geun Hong; Nam-Joon Yi; Suk-won Suh; Tae Yoo; Hyeyoung Kim; Min-Su Park; YoungRok Choi; Kyungbun Lee; Kwang-Woong Lee; Myoung Hee Park; Kyung-Suk Suh
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.